Author

E. Casanova

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:electrophysiology· 1 Organism:human· 1 Assay:metabolomics· 1

Frequent Co-Authors

A. C. Mueller· 1 shared A. Malnasi-Csizmadia· 1 shared A. Mike· 1 shared A. Rendeiro· 1 shared A. Ringler· 1 shared B. Biri-Kovacs· 1 shared B. Guertl· 1 shared C. Bock· 1 shared

Activity by Year

2017-2018 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. C. Mueller

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MTHFD1 is a genetic interactor of BRD4 and links folate metabolism to transcriptional regulation

S. Sdelci, A. Rendeiro, P. Rathert, G. Hofstaetter, A. Ringler, H. P. Moll, W. You, K. Klavins, B. Guertl, M. Farlik, S. Schick, F. Klepsch, M. Oldach, P. Buphamalai, F. Schischlik, , S. Kubicek

This study identifies MTHFD1 as a genetic and physical interactor of BRD4, linking folate metabolism to transcriptional regulation and showing synergistic effects on cancer cell viability.

bioRxiv · Oct 10, 2018Cancer Biology

Non-blocking modulation contributes to sodium channel inhibition by a covalently attached photoreactive riluzole analog

P. Lukacs, M. C. Foldi, L. Valanszki, E. Casanova, B. Biri-Kovacs, L. Nyitray, A. Malnasi-Csizmadia, A. Mike

This study shows that non-blocking modulation of sodium channels is possible using a covalently attached photoreactive riluzole analog, suggesting new avenues for drug development.

bioRxiv · Dec 4, 2017Pharmacology & Toxicology